Thanks cabel....
I'm a message board junkie, a little OCD to put it mildly when it comes to the stock market.
I don't have any fixed plans because so much is predicated on the results of the trial obviously. I have a sizeable position, and if the PPS were to pop to something in and around $10 CDN per share I'd have a hard time not taking some money off the table, irrespective of my what my opinion might be about the potential for $20, $30 maybe even $100 at the current share structure.
That Biogen news, how their Market Cap dropped $16 billion USD after their Ph III Alzheimer's trial was halted....that really gets the wheels spinning.
Imagine if BETonMACE's MOCA test results indicate a strong potential for that patient population...right now the MC for RVX is only about $500 million USD. $16 billion would represent a 32 fold increase in our PPS...so I don't think its out of the realm of possibility to consider $100 as being realistic.
Your main question is about what convinces me that the Primary goal will be met. In point of fact what I am most convinced about is that shares of Resverlogix are undergoing what I consider "smart money" accumulation.
That's opinion of course...and if I'm right the most logical reason would probably be that its because BETonMACE is poised for success. But not necessarily, a lot of shares were sold after the Assure trial failed. Buyers obviously were the winners then....
I rely heavily on the trading and chart....but I weigh the TA off against the fundamental picture with an eye out for news/hype/promotion. If a company seems to be doing all it can to attract attention, then I consider any signs of accumulation to likely be of the dumb money variety.
If you want to taste the fruit, you have to go out on a limb. But if you wait for the herd to move out on the limb....the branch tends to snap.
